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I. lNTROBUCTlON 
The lipoxygenasc of rabbi1 rcticulocyces i able to ox- 
yscnncc not only free polycnoic fatty acids but also 
more complex substrates, uch as phospholipids [ 1 J and 
biological membranes [2], Some years ago, Nekrasov 
and coworkers [3] investigated the interaction of this 
enzyme with cholesceryl arachidonace and concluded 
from the spectral changes of the incubation mixture 
that, in contrast o the soybean enzyme, the reticulocyte 
lipoxygenasc may oxygenate cholesterol esters. 
Cholesterol esters are important constituents of 
human lipoproteins, particularly of LDL. In the past 
few years it became generally accepted that oxidatively 
modified LDL play an important role in the early events 
of chc pathogen&s of atherosclerosis [4,5]. The 
mechanism of the reactions leading to the oxidative 
modifications of the lipoproteins are not completely 
understood, There is, however, a substantial body of 
experimental evidence which strongly suggests that 
autoxidation processes [6] may lead to oxidative 
modification lipoproteins. On the other hand, 
Steinberg and coworkers found that the arachidonate 
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154ipoxygcnnsc of the cndothrlial cells may also be in- 
volved in these processes [7]. More recently, McNally et 
al. showed chat human monocyrcs arc able to oxidize 
LDL via the lipoxygcnasc pathway [8]. The recent 
reports of the possible involvement of lipoxygcnascs in
the oxidative modification of lipoproteins prompted us 
to investigate chc interaction of a mammalian 
154ipoxygenase with cholesterol esters which arc im- 
portant constituents of lipoproteins. The data presented 
indicate that cholesterol esters can be oxygenated by 
lipoxygenascs and chat the product pattern formed was 
very similar to that observed for the oxygenation of the 
free fatty acids. 
2, MATERIALS AND METHODS 
The chemicals used wcrc from the following sources: cholcsteryl 
iinoleatc, cholestcryl arachidonatc, cholcsteryl iirlolcnntc and sodium 
cholate from Serve (FRG); sodium borohydride and silica gel 
(OJS-O,Z mm particle size) from Merck (Germany). All solvents used 
were of analytical grade and distilled prior to use. 
2.2. Oxy,graphic ussay 
1 mg of cholesterol esters was suspended in 10 ml of 0.1 M 
phosphate buffer, pi-l 7.4, containing O,I% sodium cholate and 
sonicated with a Branson B-l 2 sonifier for 1 min at 100 W. The turbid 
suspension was incubated with the rcticulocyte lipoxygenasr: (40 
nkat/ml linoleate oxygenase activity* for IOmin at room temperature 
in a 2 ml oxygraphic assay chamber equipped with a Clark-type 
oxygen electrode. The oxygraphic scale was calibrated by oxidation of 
known amounts of NADH by beef heart submitochoudrial particles 
[2]. 
2.3. Prcpararions 
The reticulocyte lipoxygenase was purified as described in [9]. Peak 
fractions of the isoelectric focusing (pure enzyme) or the ammonium 
--. 
“1 nkat is defined as substrate turnover of 1 nmol/s 










Fig, 2, WHPLC of tlrs clralcrtcrol cstces from human blood plasmn 
before nnd ahcr lipoxygcnasc treatment. ‘The cholcstcrot cdtcrs 
prepared from human blood pk~srna (100 &ml) were incubated with 
rcticulocytc lipoxyeenasc as described in Materials and Methods, 
After barohydridc ccduction the lipids wcrcextructcd and annlyrcd by 
SPHPLC wih the solvent system acctonitril/2~propn~ol(75:25, v/v) 
and a flow rn~cof I ml/min. The absorbansrs a1210and 235 nm were 
recorded simultaneously. (A) Before lipoxygenasc trentmcnt, dctcc- 
tiott at 210 nm. (B) Rcforc lipoxygcnasc treatment, detection at 235 
nm. (C) After lipoxygennse treatmet& detection at 239 ntn. I. 
cholestcryl arechidonate; II, cholcstcryl tinoleatc; 111, cholestrryl 
olcate; IV, cholcstcryl palmitatc. 
jugated diene chromophore with an absorbance max- 
imum at 234 nm. An almost identical chromatogram 
was obtained if the oxygenated cholesterol esters were 
not reduced with borohydride (not shown) indicating 
that hydroxy *and hydroperoxy derivatives of the 
cholesterol esters have similar etention times under our 
chromatographis conditions. Furthermore, we did not 
detect any differences in the product pattern if the QX- 
ygenation was carried out with the pure enzyme (peak 
fraction of isoelectric focussing) or an crude enzyme 
preparation (ammonium sulfate precipitate). Oxygena- 
tion of the commercially available cholesterol esters did 
also lead to the formation of products containing a con- 
jugated diene chromophore. The retention times of the 
products formed from the different substrates were 
somewhat different: 10.8 for the oxygenated cholesteryl 
linoleate, 9.8 for the oxygenated cholesteryl linolenate 
and 8.9 for the oxygenated cholesteryl arachidonate. 
Fig. 3. SD-HPLC of the fatty acid component of cholesterol esters 
from human blood plasma after lipoxygcnase treatment. The 
cholesterol esters obtained from human blood plasma were ox- 
ygenated with the reticulocyte lipoxygenase (pure enzyme) as describ- 
ed in Materials and Methods. After borohydride reduction, lipid ex- 
traction and alkaline hydrolysis the oxygenated polyenoic fatty acids 
were prepared by RP-NPLC and further analyzed by SP-HPLC with 
the solvent system: n-hexane/2qropanollacetic acid (100:2:0.1, v/v). 
“The chemical structure of all products has been identified by 
cochromarography with authentic standards, by LJV-spectroscopy 
and GC/M§ of the native trimethytsilyl ethers and their hydrogenated 
derivatives 
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We examincrl the lipid extracts of atherasclcroric le- 
sions and ‘normal’ looking regions of 5 diffcrsnr aor- 
tas. In Fig. 4 a representntivc WPLC analysis of a lipid 
extract of BIT atherosclerotic plaque is shown. It can be 
seen that the pattern of the non-oxygenated cholesterol 
cstcrs (lower trace) is very similar to that detected in the 
human plasma. In addition, large amounts caf free 
chaltstcrol were found. Recording the chromntogram 
at 235 nm (upper traec) oxygrnntcd cholesterol esters 
were dctectcd. The amount of these compounds varied 
between 17 and 55 mg/g wet weight for the 5 samples, 
Fig. 4. SP-HPLC of the cholesterol esters isolated from 
atherosclerotic lesions of human aorta. The total lipids were extracted 
from atherosclerotic plaques of a human aorta as described in 
Materials and Methods. The cholesterol esters were analyzed by SP- 
HPLC with the sokent system acetonitril/isopropanol (75:25, v/v) 
and a fiow rate of i ml/mln. The absorbance at 210 nm and 235 nm 
were recorded simultaneously. I, free cholesterol; II, oxygenated 
cholesterol esters; 111, cholesteryl arachidonate; IV, cholesteryl 
linoleate; V, cholesteryl oleate and cholcsteryl palmitate. Inset: UV- 
spectrum recorded at the times indicated. 
Calculation of the oxyg&natcCl/nan~sxyecrr#tetl 
eholrstcrol user ratio indicated that 12.4-21% (in the 5 
different samples) of the cholcsreryl linolcnte was prc- 
sent as oxygenated derivatives. In order to exclude that 
the oxygenated cholesterol esters were formed during 
the work-up procedure, radioactively labelled merl~yl 
linslcatc was added to the homogenization mixture. In 
HPLC analysis no oxygenated methyl linoleatc 
derivatives were dctceted. In ‘healthy’ looking regions 
of the sa~nc aortas much smaller amounts of ox- 
ygcnatcd cholcstcrol esters were detcctcd (ranging from 
0.3 to 4.5 mg/g wet weigth). In these samples the ox- 
ygcllatcd/non.oxygcnatcd cholcsteryl linolcatc ratio 
ranged from S,8% to 9.5%. The differences in the ox- 
ygcllatcd/non.oxygcnared cl~olcstcrol ester ratios in 
‘healthy looking regions and athcrosclcrotic lesions of 
each aorta wrre highly significant (P<O.OOl) as in- 
dicated by the paired f-test. 
Continuous recording of UV-spectra across the peak 
(peak purity search) indicated that the peak was not 
homogeneous but consisted at least of two different 
compounds with different spectral properties (inset to 
Fig. 4). Alkaline hydrolysis of the compounds absorb- 
ing at 235 nm and SP-HPLC of the resulting free fatty 
acid derivatives indicated a complex mixture of ox- 
ygenated linoleic acid derivatives. 
4. DISCUSSION 
The data presented here indicate that the lipox- 
ygcnase from rabbit reticulocytes, a mammalian 
arachidonate 1 Nipoxygenase, is able to oxygenate 
cholesterol esters which contain polyenoic fatty acids. 
These findings might be of impprtance for the 
patliogencsis of the early events of atherosclerosis. It 
has been suggested before that the oxygenation of low 
density lipoproteins by the endothelial cell or monocyte 
lipoxygenase may lead to oxidative modifications of the 
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As compared with free fatty acids, the oxygenation 
rate of choles~eral cstcrs is about three orders of 
magnitude lower. This finding is not surprising since 
other complrx lipoxygcnase substrates such ;IS 
biological membranes [2] or lipoproteins (unpublished 
data) arc also oxygenaced with a low rate. It is proposed 
that the availability of the polycnoic fatty acid residues 
for the cnzymc is stcrically hindered in the complex 
substrates. In the case of the cholestcral esters, the low 
water solubility may also contribute to the low oxygcnn- 
tion rate. 
The product specificity of the oxygenation of 
cholcstcrol esters is very similar to that of other 
substrates [ 1,2,17]. With the human plasma cholcsrerol 
esters, however, the product specificity was not very 
high since substantial amounts of racemic side products 
were formed. Similar results have been rcportcd for the 
oxygenation of biomembrancs by the pure rcciculocytc 
lipoxygcnase [2]. The product specificity Of the lipox- 
ygcnase reaction appears not to be an absolute enzyme 
property but dcpcnds on the reaction conditions, such 
as substrate concentration or reaction temperature [2]. 
Therefore, an unspecific product pattern does not 
ncccssarily exclude the lipoxygenasc origin of ox- 
ygenated lipids, 
The detection of oxygenated cholesterol esters in 
athcrosclerocic plaques of human aorta confirms earlier 
findings by Harland et al. who isolated hydroperoxides 
of cholesteryl linoleate from the lipids of advanced 
atherosclerotic plaques [ 181. Our results uggest hat the 
degree of oxidative modification of the aorta lipids 
(quantified by the oxygenated/non-oxygenated 
cholesterol ester ratio) appears to correlate with the 
stage of the atherosclerotic lesion. In fibrous plaques, a 
high oxygenated/non-oxygenated cholesterol ester atio 
was found. In ‘normal’ looking aortic tissue this ratio 
was significantly lower. In the fatty streaks which are 
recognized as early atherosclerotic lesions this ratio was 
thwn in tlro plaqw (&ma nrpt whawn), The mcehwnlsm 
at’ Formarion of thsxc pruducrs in viva rcmeina IO bc 
clarified. It cannot be oampldroly ~txrluttc(t rhar a .~~rnll 
part aY lhrt nxygcnarcd chslsnrcriJl r*terf arc Ic3rmccl in 
siru during tht? time bclwccn death and uutapxy. Aftor 
rcntovai of the aortas aufexidatian procerrcs wcrc 
Iar#cly inhibircd by the xtc3rrrgc conditions and fhr 
werk-up protocol (see Mstcrialx rend Methods). Accor- 
ding to our cxpcrirncdff lipid pc33xidation in animal 
tissue does nal take plrcc if the liatuc is handled ac- 
cording ff3 our protcacol. Furthcrmorr, aursxidationa 
during homogcniaa~ion, lipid extraction and extract 
storage Ciln br Cxcluded us indicetcd by the control ex- 
pcrim&ts with radioactively labelled methyl linoleafc. 
Therefore it is concludrd that the oxygenated 
cholcstersl esters arc Farmed in viva and that their for- 
mation may hc involvctd in the pnthogencsis of 
athcrnsclcrosisa 
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